{"entity":{"type":"insider","cik":"0001801372","url":"/insider/0001801372","json_url":"/insider/0001801372.json","name":"Lee Jennifer Kayden","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":20,"first":"2022-02-15","last":"2026-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Lee Jennifer Kayden","source":"filing","n_filings":16,"first_seen":"2023-08-09","last_seen":"2026-08-14"},{"name":"Chien Jennifer","source":"filing","n_filings":4,"first_seen":"2022-02-15","last_seen":"2023-02-14"}],"transactions":[{"id":9294263,"accession":"0001649904-26-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001649904-26-000009","line_url":"/filing/0001649904-26-000009#line-1","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75834.0,"shares_display":"75,834","price_per_share":117.3818,"price_display":"117.38","price_state":"stated","total_value":8901531.4212,"total_display":"8,901,531.42","total_whole":"8,901,531","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-13","filed_date":"2026-08-14","scope":"insider"},{"id":4955324,"accession":"0001104659-25-015320","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-015320","line_url":"/filing/0001104659-25-015320#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2035.0,"shares_display":"2,035","price_per_share":57.22,"price_display":"57.22","price_state":"stated","total_value":116442.7,"total_display":"116,442.70","total_whole":"116,443","shares_owned_after":5858.0,"shares_owned_after_display":"5,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-19","scope":"insider"},{"id":4955305,"accession":"0001104659-25-014257","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-014257","line_url":"/filing/0001104659-25-014257#line-4","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1205.0,"shares_display":"1,205","price_per_share":58.0,"price_display":"58.00","price_state":"stated","total_value":69890.0,"total_display":"69,890.00","total_whole":"69,890","shares_owned_after":2393.0,"shares_owned_after_display":"2,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider"},{"id":4955301,"accession":"0001104659-25-014257","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-014257","line_url":"/filing/0001104659-25-014257","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1815.0,"shares_display":"1,815","price_per_share":56.39011019283747,"price_display":"56.39","price_state":"stated","total_value":102348.05,"total_display":"102,348.05","total_whole":"102,348","shares_owned_after":3598.0,"shares_owned_after_display":"3,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-12","filed_date":"2025-02-14","scope":"insider","n_lines":3},{"id":4799219,"accession":"0001104659-25-011677","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-25-011677","line_url":"/filing/0001104659-25-011677","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1027.0,"shares_display":"1,027","price_per_share":57.50996105160662,"price_display":"57.51","price_state":"stated","total_value":59062.73,"total_display":"59,062.73","total_whole":"59,063","shares_owned_after":5417.0,"shares_owned_after_display":"5,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-11","filed_date":"2025-02-11","scope":"insider","n_lines":2},{"id":4799207,"accession":"0001104659-25-011677","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-011677","line_url":"/filing/0001104659-25-011677","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4189.0,"shares_display":"4,189","price_per_share":58.912174552399144,"price_display":"58.91","price_state":"stated","total_value":246783.0992,"total_display":"246,783.10","total_whole":"246,783","shares_owned_after":4409.0,"shares_owned_after_display":"4,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-11","scope":"insider","n_lines":2},{"id":5083480,"accession":"0001104659-25-010610","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-010610","line_url":"/filing/0001104659-25-010610","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3066.0,"shares_display":"3,066","price_per_share":60.54801089367254,"price_display":"60.55","price_state":"stated","total_value":185640.2014,"total_display":"185,640.20","total_whole":"185,640","shares_owned_after":2305.0,"shares_owned_after_display":"2,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-07","scope":"insider","n_lines":3},{"id":4167978,"accession":"0001104659-25-009284","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-009284","line_url":"/filing/0001104659-25-009284#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1447.0,"shares_display":"1,447","price_per_share":59.43,"price_display":"59.43","price_state":"stated","total_value":85995.21,"total_display":"85,995.21","total_whole":"85,995","shares_owned_after":4038.0,"shares_owned_after_display":"4,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-04","scope":"insider"},{"id":2372883,"accession":"0001104659-24-117942","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-24-117942","line_url":"/filing/0001104659-24-117942","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66861.0,"shares_display":"66,861","price_per_share":66.32988472053962,"price_display":"66.33","price_state":"stated","total_value":4434882.4223,"total_display":"4,434,882.42","total_whole":"4,434,882","shares_owned_after":29782.0,"shares_owned_after_display":"29,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider","n_lines":4},{"id":2599566,"accession":"0001104659-24-037880","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-037880","line_url":"/filing/0001104659-24-037880","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18235.0,"shares_display":"18,235","price_per_share":38.7718650945983,"price_display":"38.77","price_state":"stated","total_value":707004.96,"total_display":"707,004.96","total_whole":"707,005","shares_owned_after":15918.0,"shares_owned_after_display":"15,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-20","filed_date":"2024-03-22","scope":"insider","n_lines":2},{"id":3268353,"accession":"0001104659-24-036312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-036312","line_url":"/filing/0001104659-24-036312#line-1","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15515.0,"shares_display":"15,515","price_per_share":39.22,"price_display":"39.22","price_state":"stated","total_value":608498.3,"total_display":"608,498.30","total_whole":"608,498","shares_owned_after":25087.0,"shares_owned_after_display":"25,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-19","scope":"insider"},{"id":3153796,"accession":"0001104659-24-022538","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-022538","line_url":"/filing/0001104659-24-022538#line-4","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":615.0,"shares_display":"615","price_per_share":49.83,"price_display":"49.83","price_state":"stated","total_value":30645.45,"total_display":"30,645.45","total_whole":"30,645","shares_owned_after":6852.0,"shares_owned_after_display":"6,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-13","scope":"insider"},{"id":3153795,"accession":"0001104659-24-022538","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-022538","line_url":"/filing/0001104659-24-022538#line-3","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1023.0,"shares_display":"1,023","price_per_share":51.38,"price_display":"51.38","price_state":"stated","total_value":52561.74,"total_display":"52,561.74","total_whole":"52,562","shares_owned_after":7467.0,"shares_owned_after_display":"7,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":2862393,"accession":"0001104659-24-010800","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-010800","line_url":"/filing/0001104659-24-010800#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1492.0,"shares_display":"1,492","price_per_share":45.06,"price_display":"45.06","price_state":"stated","total_value":67229.52,"total_display":"67,229.52","total_whole":"67,230","shares_owned_after":3021.0,"shares_owned_after_display":"3,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-05","scope":"insider"},{"id":7804287,"accession":"0001104659-23-119095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-119095","line_url":"/filing/0001104659-23-119095#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13677.0,"shares_display":"13,677","price_per_share":32.0113,"price_display":"32.01","price_state":"stated","total_value":437818.5501,"total_display":"437,818.55","total_whole":"437,819","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-16","scope":"insider"},{"id":7804272,"accession":"0001104659-23-117365","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-23-117365","line_url":"/filing/0001104659-23-117365","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3438.0,"shares_display":"3,438","price_per_share":27.6856,"price_display":"27.69","price_state":"stated","total_value":95183.0928,"total_display":"95,183.09","total_whole":"95,183","shares_owned_after":1647.0,"shares_owned_after_display":"1,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-09","filed_date":"2023-11-13","scope":"insider","n_lines":2},{"id":7804265,"accession":"0001104659-23-117365","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-117365","line_url":"/filing/0001104659-23-117365","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5712.0,"shares_display":"5,712","price_per_share":28.904824019607844,"price_display":"28.90","price_state":"stated","total_value":165104.3548,"total_display":"165,104.35","total_whole":"165,104","shares_owned_after":3880.0,"shares_owned_after_display":"3,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-08","filed_date":"2023-11-13","scope":"insider","n_lines":2},{"id":7804225,"accession":"0001104659-23-115368","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-115368","line_url":"/filing/0001104659-23-115368#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80.0,"shares_display":"80","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":2240.0,"total_display":"2,240.00","total_whole":"2,240","shares_owned_after":1647.0,"shares_owned_after_display":"1,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-03","filed_date":"2023-11-07","scope":"insider"},{"id":7925207,"accession":"0001104659-23-099017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-099017","line_url":"/filing/0001104659-23-099017#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6166.0,"shares_display":"6,166","price_per_share":28.0502,"price_display":"28.05","price_state":"stated","total_value":172957.5332,"total_display":"172,957.53","total_whole":"172,958","shares_owned_after":1647.0,"shares_owned_after_display":"1,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-07","scope":"insider"},{"id":8290617,"accession":"0001104659-23-089331","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-089331","line_url":"/filing/0001104659-23-089331#line-4","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1718.0,"shares_display":"1,718","price_per_share":24.66,"price_display":"24.66","price_state":"stated","total_value":42365.88,"total_display":"42,365.88","total_whole":"42,366","shares_owned_after":3294.0,"shares_owned_after_display":"3,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-09","filed_date":"2023-08-09","scope":"insider"},{"id":8290608,"accession":"0001104659-23-089331","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-089331","line_url":"/filing/0001104659-23-089331#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Lee Jennifer Kayden","owner_display_name":"Lee Jennifer Kayden","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11223.0,"shares_display":"11,223","price_per_share":24.1778,"price_display":"24.18","price_state":"stated","total_value":271347.4494,"total_display":"271,347.45","total_whole":"271,347","shares_owned_after":3294.0,"shares_owned_after_display":"3,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-07","filed_date":"2023-08-09","scope":"insider"},{"id":8224222,"accession":"0001104659-23-022113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-022113","line_url":"/filing/0001104659-23-022113#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Chien Jennifer","owner_display_name":"Chien Jennifer","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":635.0,"shares_display":"635","price_per_share":26.87,"price_display":"26.87","price_state":"stated","total_value":17062.45,"total_display":"17,062.45","total_whole":"17,062","shares_owned_after":4940.0,"shares_owned_after_display":"4,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-14","scope":"insider"},{"id":9223770,"accession":"0001104659-23-022065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-022065","line_url":"/filing/0001104659-23-022065#line-1","is_derivative":false,"issuer_cik":"0001801372","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001801372","owner_cik":"0001801372","owner_name":"Chien Jennifer","owner_display_name":"Chien Jennifer","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1204.0,"shares_display":"1,204","price_per_share":27.51,"price_display":"27.51","price_state":"stated","total_value":33122.04,"total_display":"33,122.04","total_whole":"33,122","shares_owned_after":3544.0,"shares_owned_after_display":"3,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-09","filed_date":"2023-02-14","scope":"insider"},{"id":8673239,"accession":"0001104659-23-019835","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-019835","line_url":"/filing/0001104659-23-019835#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Chien Jennifer","owner_display_name":"Chien Jennifer","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1192.0,"shares_display":"1,192","price_per_share":27.66,"price_display":"27.66","price_state":"stated","total_value":32970.72,"total_display":"32,970.72","total_whole":"32,971","shares_owned_after":3556.0,"shares_owned_after_display":"3,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-09","filed_date":"2023-02-13","scope":"insider"},{"id":6629952,"accession":"0001104659-22-023948","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-023948","line_url":"/filing/0001104659-22-023948#line-2","is_derivative":false,"issuer_cik":"0001649904","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001649904","owner_cik":"0001801372","owner_name":"Chien Jennifer","owner_display_name":"Chien Jennifer","owner_url":"/insider/0001801372","role":"Officer (EVP, Head of North America)","role_mark":"O","role_mark_label":"Officer (EVP, Head of North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":722.0,"shares_display":"722","price_per_share":6.1,"price_display":"6.10","price_state":"stated","total_value":4404.2,"total_display":"4,404.20","total_whole":"4,404","shares_owned_after":1310.0,"shares_owned_after_display":"1,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-15","filed_date":"2022-02-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":37,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":37,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":37},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001649904","name":"RHYTHM PHARMACEUTICALS, INC.","url":"/issuer/0001649904","role":"Officer (EVP, Head of North America)","n_filings":20,"first_seen":"2022-02-15","last_seen":"2026-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001801372","retrieved_at":"2026-08-22T07:45:13+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}